Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1613

1.

Metal Toxicity During Short-Term Sediment Resuspension and Redeposition in a Tropical Reservoir.

Cervi EC, Hudson M, Rentschler A, Burton GA Jr.

Environ Toxicol Chem. 2019 Apr 24. doi: 10.1002/etc.4434. [Epub ahead of print]

PMID:
31017692
2.

Effects of an Intensive Discharge Intervention on Medication Adherence, Glycemic Control, and Readmission Rates in Patients With Type 2 Diabetes.

Magny-Normilus C, Nolido NV, Borges JC, Brady M, Labonville S, Williams D, Soukup J, Lipsitz S, Hudson M, Schnipper JL.

J Patient Saf. 2019 Apr 18. doi: 10.1097/PTS.0000000000000601. [Epub ahead of print]

PMID:
31009408
3.

Treatment patterns and disease outcomes for pediatric patients with refractory or recurrent Hodgkin lymphoma treated with curative-intent salvage radiotherapy.

Tinkle CL, Williams NL, Wu H, Wu J, Kaste SC, Shulkin BL, Talleur AC, Flerlage JE, Hudson MM, Metzger ML, Krasin MJ.

Radiother Oncol. 2019 May;134:89-95. doi: 10.1016/j.radonc.2019.01.026. Epub 2019 Feb 5.

PMID:
31005229
4.

Snuff box radial access: A technical note on distal radial access for neuroendovascular procedures.

Rajah G, Garling RJ, Hudson M, Luqman A.

Brain Circ. 2019 Jan-Mar;5(1):36-40. doi: 10.4103/bc.bc_2_19. Epub 2019 Mar 27. No abstract available.

5.

Cues to intention bias action perception toward the most efficient trajectory.

McDonough KL, Hudson M, Bach P.

Sci Rep. 2019 Apr 18;9(1):6472. doi: 10.1038/s41598-019-42204-y.

6.

Harmonization of pipeline for detection of HFOs in a rat model of post-traumatic epilepsy in preclinical multicenter study on post-traumatic epileptogenesis.

Santana-Gomez C, Andrade P, Hudson MR, Paananen T, Ciszek R, Smith G, Ali I, Rundle BK, Ndode-Ekane XE, Casillas-Espinosa PM, Immonen R, Puhakka N, Jones N, Brady RD, Perucca P, Shultz SR, Pitkänen A, O'Brien TJ, Staba R.

Epilepsy Res. 2019 Mar 15. pii: S0920-1211(18)30612-0. doi: 10.1016/j.eplepsyres.2019.03.008. [Epub ahead of print]

PMID:
30981541
7.

Comparative safety of abatacept in rheumatoid arthritis with COPD: A real-world population-based observational study.

Suissa S, Hudson M, Dell'Aniello S, Shen S, Simon TA, Ernst P.

Semin Arthritis Rheum. 2019 Mar 16. pii: S0049-0172(19)30023-X. doi: 10.1016/j.semarthrit.2019.03.007. [Epub ahead of print]

PMID:
30979397
8.

Effect of Reduced Audibility on Mini-Mental State Examination Scores.

Gaeta L, Azzarello J, Baldwin J, Ciro CA, Hudson MA, Johnson CE, John AB.

J Am Acad Audiol. 2019 Mar 7. doi: 10.3766/jaaa.17139. [Epub ahead of print]

PMID:
30969908
9.

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.

Ferdowsi N, Huq M, Stevens W, Hudson M, Wang M, Tay T, Burchell JL, Mancuso S, Rabusa C, Sundararajan V, Prior D, Proudman SM, Baron M, Nikpour M; Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group; Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group.

Ann Rheum Dis. 2019 Mar 30. pii: annrheumdis-2018-214764. doi: 10.1136/annrheumdis-2018-214764. [Epub ahead of print]

PMID:
30928903
10.

Letter in response to 'Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors'.

Leclair V, Landon-Cardinal O, Hudson M.

Eur J Cancer. 2019 Mar 23;112:47-48. doi: 10.1016/j.ejca.2019.02.010. [Epub ahead of print] No abstract available.

PMID:
30913530
11.

Genome-wide association study in irradiated childhood cancer survivors identifies HTR2A for subsequent basal cell carcinoma.

Sapkota Y, Turcotte LM, Ehrhardt MJ, Howell RM, Arnold MA, Wilson CL, Leisenring W, Wang Z, Sampson J, Dagnall CL, Karlins E, Li SA, Hicks BD, Weathers R, Smith SA, Shelton K, Liu Q, Tucker MA, Chanock SJ, Zhang J, Hudson MM, Neglia JP, Armstrong GT, Robison LL, Morton LM, Bhatia S, Yasui Y.

J Invest Dermatol. 2019 Mar 22. pii: S0022-202X(19)31332-6. doi: 10.1016/j.jid.2019.02.029. [Epub ahead of print] No abstract available.

PMID:
30910758
12.

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.

Baron M, Kahaleh B, Bernstein EJ, Chung L, Clements PJ, Denton C, Domsic RT, Ferdowsi N, Foeldvari I, Frech T, Gordon JK, Hudson M, Johnson SR, Khanna D, McMahan Z, Merkel PA, Narain S, Nikpour M, Pauling JD, Ross L, Valenzuela Vergara AM, Vacca A.

J Scleroderma Relat Disord. 2019 Feb;4(1):17-27. doi: 10.1177/2397198318783926. Epub 2018 Jul 18.

13.

Analysis of Diagnoses, Symptoms, Medications, and Admissions Among Patients With Cancer Presenting to Emergency Departments.

Caterino JM, Adler D, Durham DD, Yeung SJ, Hudson MF, Bastani A, Bernstein SL, Baugh CW, Coyne CJ, Grudzen CR, Henning DJ, Klotz A, Madsen TE, Pallin DJ, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Venkat A, Wilson J, Thomas CR Jr, Bischof JJ, Lyman GH.

JAMA Netw Open. 2019 Mar 1;2(3):e190979. doi: 10.1001/jamanetworkopen.2019.0979.

PMID:
30901049
14.

Genomic Research Through an Indigenous Lens: Understanding the Expectations.

Garrison NA, Hudson M, Ballantyne LL, Garba I, Martinez A, Taualii M, Arbour L, Caron NR, Carroll Rainie S.

Annu Rev Genomics Hum Genet. 2019 Mar 20. doi: 10.1146/annurev-genom-083118-015434. [Epub ahead of print]

PMID:
30892943
15.

Ag-doped ZnO nanorods embedded reduced graphene oxide nanocomposite for photo-electrochemical applications.

Khurshid F, Jeyavelan M, Hudson MSL, Nagarajan S.

R Soc Open Sci. 2019 Feb 6;6(2):181764. doi: 10.1098/rsos.181764. eCollection 2019 Feb.

16.

Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis.

Munro S, Spooner L, Milbers K, Hudson M, Koehn C, Harrison M.

BMC Rheumatol. 2018 Jul 5;2:18. doi: 10.1186/s41927-018-0026-7. eCollection 2018.

17.

Impact of regional organ sharing and allocation in the UK Northern Liver Alliance on waiting time to liver transplantation and waitlist survival.

Malik AK, Masson S, Allen E, Akyol M, Bathgate A, Davies M, Hidalgo E, Hudson M, Powell J, Taylor R, Zarankaite A, Manas DM; UK Northern Liver Alliance.

Transplantation. 2019 Mar 1. doi: 10.1097/TP.0000000000002687. [Epub ahead of print]

PMID:
30830042
18.

Gonadal Functioning and Perceptions of Infertility Risk Among Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study.

Lehmann V, Chemaitilly W, Lu L, Green DM, Kutteh WH, Brinkman TM, Srivastava DK, Robison LL, Hudson MM, Klosky JL.

J Clin Oncol. 2019 Apr 10;37(11):893-902. doi: 10.1200/JCO.18.00965. Epub 2019 Feb 27.

PMID:
30811296
19.

A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort.

Kim H, Levy DM, Silverman ED, Hitchon C, Bernatsky S, Pineau C, Smith CD, Tucker L, Petty R, Arbillaga H, Zummer M, Hudson M, Fortin P, Huber AM, Chedeville G, Peschken C, Pope JE.

Rheumatology (Oxford). 2019 Feb 25. pii: kez006. doi: 10.1093/rheumatology/kez006. [Epub ahead of print]

PMID:
30805629
20.

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study.

Montastruc F, Renoux C, Hudson M, Dell'Aniello S, Simon TA, Suissa S.

Semin Arthritis Rheum. 2019 Jan 25. pii: S0049-0172(18)30410-4. doi: 10.1016/j.semarthrit.2019.01.009. [Epub ahead of print]

PMID:
30772001
21.

Comorbidity of diabetes mellitus in idiopathic normal pressure hydrocephalus: a systematic literature review.

Hudson M, Nowak C, Garling RJ, Harris C.

Fluids Barriers CNS. 2019 Feb 12;16(1):5. doi: 10.1186/s12987-019-0125-x. Review.

22.

The genome of the soybean cyst nematode (Heterodera glycines) reveals complex patterns of duplications involved in the evolution of parasitism genes.

Masonbrink R, Maier TR, Muppirala U, Seetharam AS, Lord E, Juvale PS, Schmutz J, Johnson NT, Korkin D, Mitchum MG, Mimee B, den Akker SE, Hudson M, Severin AJ, Baum TJ.

BMC Genomics. 2019 Feb 7;20(1):119. doi: 10.1186/s12864-019-5485-8.

23.

Harmonization of lateral fluid-percussion injury model production and post-injury monitoring in a preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis.

Ndode-Ekane XE, Santana-Gomez C, Casillas-Espinosa PM, Ali I, Brady RD, Smith G, Andrade P, Immonen R, Puhakka N, Hudson MR, Braine EL, Shultz SR, Staba RJ, O'Brien TJ, Pitkänen A.

Epilepsy Res. 2019 Mar;151:7-16. doi: 10.1016/j.eplepsyres.2019.01.006. Epub 2019 Jan 18.

PMID:
30711714
24.

Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.

Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL.

J Scleroderma Relat Disord. 2018 Oct;3(3):249-252. doi: 10.1177/2397198318774307. Epub 2018 May 24.

25.

Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.

Feijen EAM, Leisenring WM, Stratton KL, Ness KK, van der Pal HJH, van Dalen EC, Armstrong GT, Aune GJ, Green DM, Hudson MM, Loonen J, Oeffinger KC, Robison LL, Yasui Y, Kremer LCM, Chow EJ.

JAMA Oncol. 2019 Jan 31. doi: 10.1001/jamaoncol.2018.6634. [Epub ahead of print]

PMID:
30703192
26.

Motivations for data sharing-views of research participants from four European countries: A DIRECT study.

Shah N, Coathup V, Teare H, Forgie I, Giordano GN, Hansen TH, Groeneveld L, Hudson M, Pearson E, Ruetten H, Kaye J.

Eur J Hum Genet. 2019 May;27(5):721-729. doi: 10.1038/s41431-019-0344-2. Epub 2019 Jan 30.

PMID:
30700834
27.

Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia.

Krull KR, Li C, Phillips NS, Cheung YT, Brinkman TM, Wilson CL, Armstrong GT, Khan RB, Merchant TE, Sabin ND, Srivastava D, Pui CH, Robison LL, Hudson MM, Sklar CA, Chemaitilly W.

Cancer. 2019 Jan 28. doi: 10.1002/cncr.31975. [Epub ahead of print]

PMID:
30690723
28.

18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications.

Maliha PG, Hudson M, Abikhzer G, Singerman J, Probst S.

Nucl Med Commun. 2019 Apr;40(4):377-382. doi: 10.1097/MNM.0000000000000981.

PMID:
30664602
29.

Adverse events associated with immune checkpoint inhibitor treatment for cancer.

Esfahani K, Meti N, Miller WH Jr, Hudson M.

CMAJ. 2019 Jan 14;191(2):E40-E46. doi: 10.1503/cmaj.180870. Review. No abstract available.

PMID:
30642824
30.

Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology.

Butler EA, Baron M, Fogo AB, Frech T, Ghossein C, Hachulla E, Hoa S, Johnson SR, Khanna D, Mouthon L, Nikpour M, Proudman S, Steen V, Stern E, Varga J, Denton C, Hudson M; Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working Group.

Arthritis Rheumatol. 2019 Jan 7. doi: 10.1002/art.40809. [Epub ahead of print]

PMID:
30614663
31.

Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.

Clemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R, Constine LS, Bass JK, Kuehni CE, Langer T, van Dalen EC, Bardi E, Bonne NX, Brock PR, Brooks B, Carleton B, Caron E, Chang KW, Johnston K, Knight K, Nathan PC, Orgel E, Prasad PK, Rottenberg J, Scheinemann K, de Vries ACH, Walwyn T, Weiss A, Am Zehnhoff-Dinnesen A, Cohn RJ, Landier W; International Guideline Harmonization Group ototoxicity group.

Lancet Oncol. 2019 Jan;20(1):e29-e41. doi: 10.1016/S1470-2045(18)30858-1. Review.

PMID:
30614474
32.

He Pikinga Waiora: supporting Māori health organisations to respond to pre-diabetes.

Beaton A, Manuel C, Tapsell J, Foote J, Oetzel JG, Hudson M.

Int J Equity Health. 2019 Jan 7;18(1):3. doi: 10.1186/s12939-018-0904-z.

33.

Informatics tools to assess the success of procedural harmonization in preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis.

Ciszek R, Ndode-Ekane XE, Gomez CS, Casillas-Espinosa PM, Ali I, Smith G, Puhakka N, Lapinlampi N, Andrade P, Kamnaksh A, Immonen R, Paananen T, Hudson MR, Brady RD, Shultz SR, O'Brien TJ, Staba RJ, Tohka J, Pitkänen A.

Epilepsy Res. 2019 Feb;150:17-26. doi: 10.1016/j.eplepsyres.2018.12.010. Epub 2018 Dec 27.

PMID:
30605864
34.

Identification and Characterization of Oral Injury in Suspected Child Abuse Cases: One Health System's Experience.

George CLS, Theesfeld SSN, Wang Q, Hudson MJ, Harper NS.

Pediatr Emerg Care. 2018 Dec 28. doi: 10.1097/PEC.0000000000001715. [Epub ahead of print]

PMID:
30601344
35.

Chronic pain clinic efficiency analysis: optimization through use of the Gantt diagram and visit diagnoses.

Hundley HE, Hudson ME, Wasan AD, Emerick TD.

J Pain Res. 2018 Dec 17;12:1-8. doi: 10.2147/JPR.S173345. eCollection 2019.

36.

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

Goode EC, Clark AB, Mells GF, Srivastava B, Spiess K, Gelson WTH, Trivedi PJ, Lynch KD, Castren E, Vesterhus MN, Karlsen TH, Ji SG, Anderson CA, Thorburn D, Hudson M, Heneghan MA, Aldersley MA, Bathgate A, Sandford RN, Alexander GJ, Chapman RW, Walmsley M; UK-PSC Consortium, Hirschfield GM, Rushbrook SM.

Hepatology. 2019 May;69(5):2120-2135. doi: 10.1002/hep.30479. Epub 2019 Mar 4.

PMID:
30566748
37.

Coronary CTA reduced risk for coronary events at 5 years in patients with stable chest pain.

Hudson MP.

Ann Intern Med. 2018 Dec 18;169(12):JC70. doi: 10.7326/ACPJC-2018-169-12-070. No abstract available.

PMID:
30557423
38.

Harmonization of pipeline for preclinical multicenter plasma protein and miRNA biomarker discovery in a rat model of post-traumatic epileptogenesis.

Kamnaksh A, Puhakka N, Ali I, Smith G, Aniceto R, McCullough J, Das Gupta S, Ndode-Ekane XE, Brady R, Casillas-Espinosa P, Hudson M, Santana-Gomez C, Immonen R, Abreu PA, Jones N, Shultz S, Staba RJ, O'Brien TJ, Agoston D, Pitkänen A.

Epilepsy Res. 2019 Jan;149:92-101. doi: 10.1016/j.eplepsyres.2018.11.009. Epub 2018 Nov 26.

PMID:
30553097
39.

Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study.

Montastruc F, Renoux C, Dell'Aniello S, Simon TA, Azoulay L, Hudson M, Suissa S.

Rheumatology (Oxford). 2019 Apr 1;58(4):683-691. doi: 10.1093/rheumatology/key352.

PMID:
30535094
40.

Long-term health and social function in adult survivors of paediatric astrocytoma: A report from the Childhood Cancer Survivor Study.

Effinger KE, Stratton KL, Fisher PG, Ness KK, Krull KR, Oeffinger KC, Armstrong GT, Robison LL, Hudson MM, Leisenring WM, Nathan PC.

Eur J Cancer. 2019 Jan;106:171-180. doi: 10.1016/j.ejca.2018.10.016. Epub 2018 Dec 5.

PMID:
30528801
41.

Revisiting Mission-based Productivity.

Lebovitz EE, Maddy EM, Hudson ME, Adams DC.

Int Anesthesiol Clin. 2019 Winter;57(1):114-130. doi: 10.1097/AIA.0000000000000217. No abstract available.

PMID:
30520752
42.

Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.

Richard N, Hudson M, Wang M, Gyger G, Proudman S, Stevens W, Nikpour M; Canadian Scleroderma Research Group (CSRG) ; Australian Scleroderma Interest Group (ASIG) , Baron M.

Rheumatology (Oxford). 2019 Apr 1;58(4):636-644. doi: 10.1093/rheumatology/key350.

PMID:
30517716
43.

High-Frequency Neuronal Oscillatory Abnormalities in the Phospholipase C-β1 Knockout Mouse Model of Schizophrenia.

Hudson MR, Hannan AJ, O'Brien TJ, Jones NC.

Int J Neuropsychopharmacol. 2019 Mar 1;22(3):221-231. doi: 10.1093/ijnp/pyy097.

44.

NCEPOD and alcohol-related liver disease, what are the views of those who deliver the service? A survey of consultants and trainees in North Eastern England.

Mitchison H, Saksena S, Hudson M.

J R Coll Physicians Edinb. 2018 Dec;48(4):293-298. doi: 10.4997/JRCPE.2018.402.

PMID:
30488881
45.

Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.

Williams R, Alexander G, Aspinall R, Batterham R, Bhala N, Bosanquet N, Severi K, Burton A, Burton R, Cramp ME, Day N, Dhawan A, Dillon J, Drummond C, Dyson J, Ferguson J, Foster GR, Gilmore I, Greenberg J, Henn C, Hudson M, Jarvis H, Kelly D, Mann J, McDougall N, McKee M, Moriarty K, Morling J, Newsome P, O'Grady J, Rolfe L, Rice P, Rutter H, Sheron N, Thorburn D, Verne J, Vohra J, Wass J, Yeoman A.

Lancet. 2018 Dec 1;392(10162):2398-2412. doi: 10.1016/S0140-6736(18)32561-3. Epub 2018 Nov 22.

PMID:
30473364
46.

1-h Evaluation for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay.

Nowak RM, Gandolfo CM, Jacobsen G, Christenson RH, Moyer M, Hudson M, McCord J.

J Am Coll Cardiol. 2018 Nov 27;72(21):2677-2679. doi: 10.1016/j.jacc.2018.08.2190. No abstract available.

PMID:
30466528
47.

Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence.

Hudson M, Schuchmann M.

Eur J Gastroenterol Hepatol. 2019 Apr;31(4):434-450. doi: 10.1097/MEG.0000000000001311.

48.

Publisher Correction: Allele-defined genome of the autopolyploid sugarcane Saccharum spontaneum L.

Zhang J, Zhang X, Tang H, Zhang Q, Hua X, Ma X, Zhu F, Jones T, Zhu X, Bowers J, Wai CM, Zheng C, Shi Y, Chen S, Xu X, Yue J, Nelson DR, Huang L, Li Z, Xu H, Zhou D, Wang Y, Hu W, Lin J, Deng Y, Pandey N, Mancini M, Zerpa D, Nguyen JK, Wang L, Yu L, Xin Y, Ge L, Arro J, Han JO, Chakrabarty S, Pushko M, Zhang W, Ma Y, Ma P, Lv M, Chen F, Zheng G, Xu J, Yang Z, Deng F, Chen X, Liao Z, Zhang X, Lin Z, Lin H, Yan H, Kuang Z, Zhong W, Liang P, Wang G, Yuan Y, Shi J, Hou J, Lin J, Jin J, Cao P, Shen Q, Jiang Q, Zhou P, Ma Y, Zhang X, Xu R, Liu J, Zhou Y, Jia H, Ma Q, Qi R, Zhang Z, Fang J, Fang H, Song J, Wang M, Dong G, Wang G, Chen Z, Ma T, Liu H, Dhungana SR, Huss SE, Yang X, Sharma A, Trujillo JH, Martinez MC, Hudson M, Riascos JJ, Schuler M, Chen LQ, Braun DM, Li L, Yu Q, Wang J, Wang K, Schatz MC, Heckerman D, Van Sluys MA, Souza GM, Moore PH, Sankoff D, VanBuren R, Paterson AH, Nagai C, Ming R.

Nat Genet. 2018 Dec;50(12):1754. doi: 10.1038/s41588-018-0293-7.

PMID:
30425353
49.

Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.

Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, Donaldson SS, Howell RM, Hudson MM, Mahajan A, Nathan PC, Ness KK, Sklar CA, Tonorezos ES, Weldon CB, Wells EM, Yasui Y, Armstrong GT, Robison LL, Oeffinger KC.

Lancet Oncol. 2018 Dec;19(12):1590-1601. doi: 10.1016/S1470-2045(18)30537-0. Epub 2018 Nov 8. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.

PMID:
30416076
50.

Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE).

Wang Z, Liu Q, Wilson CL, Easton J, Mulder H, Chang TC, Rusch MC, Edmonson MN, Rice SV, Ehrhardt MJ, Howell RM, Kesserwan CA, Wu G, Nichols KE, Downing JR, Hudson MM, Zhang J, Yasui Y, Robison LL.

Clin Cancer Res. 2018 Dec 15;24(24):6230-6235. doi: 10.1158/1078-0432.CCR-18-1775. Epub 2018 Oct 26.

PMID:
30366939

Supplemental Content

Loading ...
Support Center